Αμάντα Ψυρρή
Καθηγήτρια Παθολογίας Ογκολογίας Ιατρικής ΕΚΠΑ | Διευθύντρια Β’ Προπαιδευτικής Παθολογικής Κλινικής | Πανεπιστημιακό Γενικό Νοσοκομείο «Αττικόν» |
T. Επίκουρη Καθηγήτρια Πανεπιστημίου Yale, ΗΠΑ

Research findings show that every type of malignancy can be divided to subcategories depending on its molecular profile.

Molecular analysis of the tumor can show which treatment plan is suited best for each individual patient the so called ‘personalized’ or ‘targeted’ tumor therapy.

Therefore, we should mention that each individual tumor is different and has to undergo molecular analysis (for example next generation sequencing) to determine the best treatment plan for this patient.